Lung Neoplasm Malignant Clinical Trial
— PREOTESTOfficial title:
Prognostic Value of the 6-minute Stepper Test in Non-small Cell Lung Cancer Surgery
| Verified date | February 2022 |
| Source | University Hospital, Rouen |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational [Patient Registry] |
The objective of this study is to evaluate the performances of the Six-Minute Stepper Test (6MST) and Sit To Stand test (STST) to predict post-operative complications after minimally invasive lung cancer resection.
| Status | Completed |
| Enrollment | 122 |
| Est. completion date | February 4, 2020 |
| Est. primary completion date | February 4, 2020 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility | Inclusion Criteria: - Age >18 - Non-small cell lung cancer stage I to II, justifying major resection by VATS or RATS (segmentectomy, lobectomy, pneumonectomy), with or without histological confirmation Exclusion Criteria: - Partial or total amputation localized to the lower limb; - Weight greater than 100 kg; - Orthopedic, vascular or neurological disorders leading to the incapacity of realize the 6MST; - Patient under tutorship or curatorship; - Pregnant woman. - Surgery canceled |
| Country | Name | City | State |
|---|---|---|---|
| France | Boujibar , F | Rouen |
| Lead Sponsor | Collaborator |
|---|---|
| University Hospital, Rouen |
France,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | occurrence of a post-operative complication grade = 2 on the Clavien-Dindo scale within three months after surgery | 90 days |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05890872 -
Aliyaâ„¢ Pulsed Electric Fields (PEF) for Advanced Cancer
|
N/A | |
| Recruiting |
NCT05974475 -
MONDRIAN: Multi-omics Integrative Modelling for Stereotactic Body Radiotherapy in Early-stage Non-small Cell Lung Cancer
|
||
| Recruiting |
NCT06079970 -
Confocal Laser Endomicroscopy VERification
|
N/A | |
| Recruiting |
NCT04973293 -
Preoperative Sintilimab Combined With Bevacizumab and Chemotherapy for Resectable Non-Small Cell Lung Cancer
|
N/A | |
| Recruiting |
NCT04778826 -
Immune Response Following Lobectomy Along With or Without Bilateral Transcervical Mediastinal Lymphadenectomy
|
N/A | |
| Suspended |
NCT04036721 -
Coorticosteroid Regimen in Patients With Anti-PD-1/PD-L1 Induced Pneumonitis
|
Phase 4 | |
| Completed |
NCT03352245 -
Feasibility of an Activity Regimen in Patients With Advanced Stage Lung Cancer
|
N/A | |
| Completed |
NCT03834116 -
Resistance Inspiratory Muscle Training for Patients With Thoracic Malignancies
|
N/A | |
| Terminated |
NCT02985203 -
Oral Navelbine and Cisplatin Followed by Metronomic Oral Navelbine in Non-Small Cell Lung Cancer
|
Phase 2 | |
| Recruiting |
NCT06440616 -
Benefit of Spectral Information in Patients Suspected for Lung Cancer
|
N/A | |
| Active, not recruiting |
NCT05241873 -
(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations
|
Phase 1/Phase 2 | |
| Completed |
NCT05404022 -
Feasibility Trial of a Personalised Nutrition and Activity Programme for People With Lung Cancer Over 65 Years
|
N/A | |
| Not yet recruiting |
NCT05414188 -
Beneficial Effect of Pulmonary Rehabilitation in Lung Cancer Patients Receiving Radiation Therapy
|
N/A | |
| Recruiting |
NCT03525782 -
Anti-MUC1 CAR T Cells and PD-1 Knockout Engineered T Cells for NSCLC
|
Phase 1/Phase 2 | |
| Completed |
NCT04059887 -
Evaluation of Blood TMB for the Efficacy of Atezolizumab [BUDDY]
|
Phase 4 | |
| Terminated |
NCT05013554 -
Dose Escalation and Expansion Study of SAR443216 in Participants With Relapsed/Refractory HER2 Expressing Solid Tumors
|
Phase 1 |